Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06170606 · ClinicalTrials.gov registry record · NA
POLARx Post Approval Study (POLARx PAS)
A NA study of Paroxysmal Atrial Fibrillation, sponsored by Boston Scientific Corporation.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 11
- Study locations
NCT06170606 is a NA study of Paroxysmal Atrial Fibrillation that is actively recruiting participants, run by Boston Scientific Corporation. The registered enrollment target is 200 participants, below the 851-participant average among 24 other Paroxysmal Atrial Fibrillation trials with a reported enrollment target (76% lower). The trial reports 11 study locations across 8 states.
The verdict
NCT06170606, a NA study of Paroxysmal Atrial Fibrillation, is actively recruiting participants, sponsored by Boston Scientific Corporation.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 11
- Study locations
Study Summary
To collect clinical data on safety, effectiveness and procedural success of Boston Scientific's Cardiac Cryoablation System (includes all BSC commercially available POLARx/POLARx Fit catheters) when used to perform pulmonary vein isolation (PVI) in the ablation treatment of de novo Atrial Fibrillation (AF).
Conditions Studied
Interventions
- DEVICE Boston Scientific Cardiac Cryoablation System
Study Locations (11)
Arizona
- Mercy Gilbert Medical Center - Gilbert
- Banner University Medical Center Phoenix - Phoenix
- Pima Heart & Vascular Clinical Research - Tucson
Colorado
- Intermountain Platte Valley Hospital - Brighton
- Valley View Hospital - Glenwood Springs
California
- Torrance Memorial Medical Center - Torrance
Florida
- St. Joseph's Hospital/BayCare Medical Group - Tampa
Ohio
- Bethesda North Hospital - Cincinnati
South Carolina
- Prisma Health Richland Hospital - Columbia
Texas
- University of Texas Medical Branch - Galveston - Galveston
Wisconsin
- Aurora Health - Grafton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-06-28 |
| Est. Completion | 2029-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06170606
The ClinicalTrials.gov registry entry for NCT06170606 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 851-participant average among 24 other Paroxysmal Atrial Fibrillation trials with a reported enrollment target (76% lower). The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Paroxysmal Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Boston Scientific Cardiac Cryoablation System is the first listed.
NCT06170606 reports 11 study locations spanning 8 distinct geographic areas - top geographies include Arizona, Colorado, California.
Frequently Asked Questions
What is clinical trial NCT06170606 about?
NCT06170606 is a clinical study titled "POLARx Post Approval Study (POLARx PAS)". To collect clinical data on safety, effectiveness and procedural success of Boston Scientific's Cardiac Cryoablation System (includes all BSC commercially available POLARx/POLARx Fit catheters) when used to perform pulmonary vein isolation (PVI) in the ablation treatment of de novo Atrial Fibrillati...
What is the current status of trial NCT06170606?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-06-28. Estimated completion is 2029-05.
What conditions does trial NCT06170606 study?
This clinical trial studies the following conditions: Paroxysmal Atrial Fibrillation.
What interventions are being tested in trial NCT06170606?
The interventions under investigation include: Boston Scientific Cardiac Cryoablation System (DEVICE).
Who is sponsoring clinical trial NCT06170606?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06170606 being conducted?
This trial has 11 study locations across Arizona, California, Colorado, Florida, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Paroxysmal Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
RECRUITING · NA
-
Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF)
RECRUITING · NA
-
Treatment of PAF With the Synaptic System
ACTIVE NOT RECRUITING · NA
-
Meditation and Education That is Nurse Delivered for Symptom Management in Paroxysmal Atrial Fibrillation (PAF)
ACTIVE NOT RECRUITING · NA
-
Safety and Effectiveness of the Globe® Pulsed Field System for Treating Patients With Symptomatic Paroxysmal or Persistent Atrial Fibrillation
ACTIVE NOT RECRUITING · NA
-
TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.